Overview
CORT market data
Price History
CORT price chart
Valuation & Profitability
- P/E (TTM)
- 218.62 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.83 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.39 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 6.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $28.66 – $122.21 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $12.1B · P/B 11.40 · P/S 14.52.
Company News
Piper Sandler Reiterates Overweight on Corcept Therapeutics, Raises Price Target to $165Benzinga · Jul 30, 2026, 6:13 PM
Stock Market Today: Microsoft Ignites Chip Rebound as SanDisk Jumps 24%Benzinga · Jul 30, 2026, 5:28 PM
Canaccord Genuity Maintains Buy on Corcept Therapeutics, Raises Price Target to $161Benzinga · Jul 30, 2026, 3:44 PM
Lam Research, Xerox, FormFactor, Microsoft And Other Big Stocks Moving Higher On ThursdayBenzinga · Jul 30, 2026, 2:22 PM
Corcept Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates. Also, HC Wainwright raised its price target on the stock from $95 to $165.Benzinga · Jul 30, 2026, 1:24 PM
HC Wainwright & Co. Maintains Buy on Corcept Therapeutics, Raises Price Target to $165Benzinga · Jul 30, 2026, 10:30 AM
Why Microsoft Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 30, 2026, 8:29 AM
Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To KnowBenzinga · Jul 30, 2026, 6:48 AM
Corcept Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates.Benzinga · Jul 29, 2026, 8:25 PM
Corcept Therapeutics Raises FY2026 Sales Guidance from $950.000M-$1.050B to $1.100B-$1.200B vs $1.008B EstBenzinga · Jul 29, 2026, 8:08 PM